Two Sigma Advisers’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,775
| Closed | -$59.8K | – | 2537 |
|
|
2023
Q4 | $59.8K | Buy |
9,775
+8,675
| +789% | +$53.1K | ﹤0.01% | 2384 |
|
|
2023
Q3 | $5.14K | Sell |
1,100
-38,633
| -97% | -$180K | ﹤0.01% | 2354 |
|
|
2023
Q2 | $213K | Buy |
39,733
+38,016
| +2,214% | +$204K | ﹤0.01% | 2084 |
|
|
2023
Q1 | $16.9K | Sell |
1,717
-107,550
| -98% | -$1.06M | ﹤0.01% | 2528 |
|
|
2022
Q4 | $2.05M | Sell |
109,267
-79,183
| -42% | -$1.48M | 0.01% | 1233 |
|
|
2022
Q3 | $3.9M | Sell |
188,450
-64,108
| -25% | -$1.33M | 0.01% | 863 |
|
|
2022
Q2 | $5.24M | Buy |
252,558
+238,391
| +1,683% | +$4.95M | 0.01% | 753 |
|
|
2022
Q1 | $610K | Buy |
+14,167
| New | +$610K | ﹤0.01% | 1888 |
|
|
2020
Q2 | – | Sell |
-5,742
| Closed | -$513K | – | 2543 |
|
|
2020
Q1 | $513K | Buy |
5,742
+1,742
| +44% | +$156K | ﹤0.01% | 1797 |
|
|
2019
Q4 | $158K | Buy |
4,000
+1,058
| +36% | +$41.8K | ﹤0.01% | 2221 |
|
|
2019
Q3 | $72K | Buy |
2,942
+1,354
| +85% | +$33.1K | ﹤0.01% | 2134 |
|
|
2019
Q2 | $56K | Buy |
+1,588
| New | +$56K | ﹤0.01% | 2246 |
|
|
2018
Q4 | – | Sell |
-883
| Closed | -$59K | – | 2402 |
|
|
2018
Q3 | $59K | Buy |
+883
| New | +$59K | ﹤0.01% | 2171 |
|